Developing Deep Vein Thrombosis/Pulmonary Embolism (DVT/PE) Increases Chances of Dying by 54% In Cancer Patients

Share Article

Dr. Mansoor Mirza, President and CEO of Travel Medicine Inc., along with Dr. John Livermore and Dr. Awais Siddique, would like to help prevent the life-threatening blood clots caused when cancer patients leave the hospital through education on their new website http://www.preventdvtnow.com.

The Surgeon General created a call to action to prevent deep vein thrombosis (DVT) and pulmonary embolism (PE). While the need for prevention exists in the general public, it is especially high for those with active cancer. Dr. Mansoor Mirza would like to change that and help prevent life-threatening blood clots through education on their new website http://www.preventdvtnow.com.

Patients with cancer who develop deep vein thrombosis (DVT) and pulmonary embolism (PE) have a significantly higher chance of dying. The probability of death within 183 days of hospital admission is over 94% for those who have cancer and DVT/PE. Now there’s a way to help prevent this deadly combination.

Deep vein thrombosis (DVT) is a serious condition in which a blood clot forms in a deep vein, most commonly occurring in the calf or thigh muscle. If part or all of the clot breaks off and travels to the lungs, it is called a pulmonary embolism (PE). PE results in a medical emergency and can cause serious illness or death. Sudden death is the first symptom in about 25% of people who develop a PE.

For cancer patients who are already fighting for their lives, deep vein thrombosis (DVT) and pulmonary embolism (PE) is extraordinarily dangerous. The probability of death within 183 days of hospital admission is over 94% for those who have cancer and DVT/PE. Those are statistics Dr. Mansoor Mirza would like to lower.

People with cancer are often unable to be as active as others, and inactivity adds to the greater risk of DVT/PE that cancer and chemotherapy already elevate. During hospital stays, a sequential compression device (what patients sometimes call “inflating boots”) helps lower the risk. However, the need for prevention doesn’t end when they leave the hospital.

According to Dr. John Livermore, “Standard sequential compression devices (SCD) are sometimes so inconvenient, restrictive, and expensive that patients don’t buy or use them. The Medshoola Compression Pump is less than half the cost of any hospital acquired device and you can get it without a prescription so it’s easily affordable for people who truly need this type of preventable device.”

That’s why Dr. Mirza developed the Medshoola™ Compression Pump. It’s an over-the-counter SCD that’s lightweight, portable, convenient, programmable, and medically proven with an FAA-approved battery that allows its use on flights. The all-in-one design makes it easy to carry and use everywhere patients go.

To watch a video of the Medshoola™ Compression Pump in action and learn more about how you can prevent DVT/PE, visit http://www.preventdvtnow.com.

Share article on social media or email:

View article via:

Pdf Print

Contact Author

Mansoor Mirza

Mansoor Mirza MD. FACP
@Medshoola
Follow >
Medshoola
Like >
Medshoola

Follow us on
Visit website